Risk factors and comorbidities for invasive pneumococcal disease in Western Australian Aboriginal and non-Aboriginal people

被引:0
作者
Faye J. Lim
Deborah Lehmann
Aoiffe McLoughlin
Catherine Harrison
Judith Willis
Carolien Giele
Anthony D. Keil
Hannah C. Moore
机构
[1] The University of Western Australia,Telethon Kids Institute
[2] Communicable Disease Control Directorate,Western Australian Department of Health
[3] Princess Margaret Hospital for Children,Department of Microbiology, PathWest Laboratory Medicine Western Australia
关键词
Invasive pneumococcal disease; risk factors; comorbidities; pneumonia; immunization;
D O I
10.15172/pneu.2014.4/463
中图分类号
学科分类号
摘要
Australian Aboriginal people have among the highest rates of invasive pneumococcal disease (IPD) worldwide. We investigated clinical diagnosis, risk factors, comorbidities and vaccine coverage in Aboriginal and non-Aboriginal IPD cases. Using enhanced surveillance, we identified IPD cases in Western Australia, Australia, between 1997 and 2007. We calculated the proportion with risk factors and comorbidities in children (<5 years) and adults (=15 years), as well as adults living in metropolitan and non-metropolitan regions. We then calculated the proportion of cases eligible for vaccination who were vaccinated before contracting IPD. Of the 1,792 IPD cases that were reported, 355 (20%) were Aboriginal and 1,155 (65%) were adults. Pneumonia was the most common diagnosis (61% of non-Aboriginal and 49% of Aboriginal adult IPD cases in 2001–2007). Congenital abnormality was the most frequent comorbidity in non-Aboriginal children (11%). In Aboriginal children, preterm delivery was most common (14%). Ninety-one percent of non-Aboriginal and 96% of Aboriginal adults had one or more risk factors or comorbidities. In non-Aboriginal adults, cardiovascular disease (34%) was the predominant comorbidity whilst excessive alcohol use (66%) was the most commonly reported risk factor in Aboriginal adults. In adults, comorbidities were more frequently reported among those in metropolitan regions than those in non-metropolitan regions. Vaccination status was unknown for 637 of 1,082 cases post-July 2001. Forty-one percent of non-Aboriginal and 60% of Aboriginal children were eligible for vaccination but were not vaccinated. Among adults with risk factors who were eligible for vaccination and with known vaccination status, 75% Aboriginal and 94% non-Aboriginal were not vaccinated. An all-of-life immunisation register is needed to evaluate vaccine coverage and effectiveness in preventing IPD in adults.
引用
收藏
页码:24 / 34
页数:10
相关论文
共 104 条
[1]  
Roche PW(2008)Invasive pneumococcal disease in Australia, 2006 Commun Dis Intell Q Rep 32 18-30
[2]  
Krause V(1998)Invasive pneumococcal disease in Dallas County, Texas: results from populationbased surveillance in 1995 Clin Infect Dis 26 590-595
[3]  
Cook H(2005)Streptococcus pneumoniae: epidemiology, risk factors, and clinical features Semin Respir Crit Care Med 26 563-574
[4]  
Barralet J(2012)Australia’s notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System Commun Dis Intell Q Rep 36 1-69
[5]  
Coleman D(2008)Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006 Commun Dis Intell Q Rep 32 S2-S67
[6]  
Sweeny A(2013)Pneumococcal vaccination of older adults: conjugate or polysaccharide? Hum Vaccin Immunother 9 1382-1384
[7]  
Pastor P(2006)Pneumococcal Working Party of the Communicable Diseases Network Australia. Invasive pneumococcal disease in Australia, 2004 Commun Dis Intell Q Rep 30 80-92
[8]  
Medley F(2010)The changing epidemiology of invasive pneumococcal disease in Aboriginal and non-Aboriginal Western Australians from 1997 through 2007 and emergence of nonvaccine serotypes Clin Infect Dis 50 1477-1486
[9]  
Murphy TV(2009)Invasive pneumococcal disease in Western Australia: emergence of serotype 19A Med J Aust 190 166-2384
[10]  
Ortqvist A(2007)Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia? Vaccine 25 2379-689